<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">World J Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">WJP</journal-id>
<journal-title-group>
<journal-title>World Journal of Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2220-3206</issn>
<publisher>
<publisher-name>Baishideng Publishing Group Inc</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29988908</article-id>
<article-id pub-id-type="pmc">6033743</article-id>
<article-id pub-id-type="other">jWJP.v8.i2.pg51</article-id>
<article-id pub-id-type="doi">10.5498/wjp.v8.i2.51</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Parkin</surname>
<given-names>Georgia M</given-names>
</name>
<aff>Molecular Psychiatry Laboratory, the Florey Institute of Neuroscience and Mental Health, Parkville VIC 3052, Australia</aff>
<aff>CRC for Mental Health, Carlton VIC 3053, Australia. <email>georgia.parkin@florey.edu.au</email></aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Udawela</surname>
<given-names>Madhara</given-names>
</name>
<aff>Molecular Psychiatry Laboratory, the Florey Institute of Neuroscience and Mental Health, Parkville VIC 3052, Australia</aff>
<aff>CRC for Mental Health, Carlton VIC 3053, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibbons</surname>
<given-names>Andrew</given-names>
</name>
<aff>Molecular Psychiatry Laboratory, the Florey Institute of Neuroscience and Mental Health, Parkville VIC 3052, Australia</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dean</surname>
<given-names>Brian</given-names>
</name>
<aff>Molecular Psychiatry Laboratory, the Florey Institute of Neuroscience and Mental Health, Parkville VIC 3052, Australia</aff>
<aff>CRC for Mental Health, Carlton VIC 3053, Australia</aff>
<aff>Research Centre for Mental Health, the Faculty of Health, Arts and Design, Swinburne University, Hawthorne VIC 3122, Australia</aff>
</contrib>
</contrib-group>
<author-notes>
<fn>
<p>Author contributions: Parkin GM drafted the manuscript; Udawela M, Gibbons A and Dean B provided critical revisions to the manuscript.</p>
<p>Correspondence to: Georgia M Parkin, BSc, MSc, Molecular Psychiatry Laboratory, the Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville VIC 3052, Australia. <email>georgia.parkin@florey.edu.au</email></p>
<p>Telephone: +61-3-90353094</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<day>28</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>8</volume>
<issue>2</issue>
<fpage>51</fpage>
<lpage>63</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.</license-p>
</license>
</permissions>
<abstract>
<p>Glutamate is the predominant excitatory neurotransmitter in the human brain and it has been shown that prolonged activation of the glutamatergic system leads to nerve damage and cell death. Following release from the pre-synaptic neuron and synaptic transmission, glutamate is either taken up into the pre-synaptic neuron or neighbouring glia by transmembrane glutamate transporters. Excitatory amino acid transporter (EAAT) 1 and EAAT2 are Na<sup>+</sup>-dependant glutamate transporters expressed predominantly in glia cells of the central nervous system. As the most abundant glutamate transporters, their primary role is to modulate levels of glutamatergic excitability and prevent spill over of glutamate beyond the synapse. This role is facilitated through the binding and transportation of glutamate into astrocytes and microglia. The function of EAAT1 and EAAT2 is heavily regulated at the levels of gene expression, post-transcriptional splicing, glycosylation states and cell-surface trafficking of the protein. Both glutamatergic dysfunction and glial dysfunction have been proposed to be involved in psychiatric disorder. This review will present an overview of the roles that EAAT1 and EAAT2 play in modulating glutamatergic activity in the human brain, and mount an argument that these two transporters could be involved in the aetiologies of schizophrenia and affective disorders as well as represent potential drug targets for novel therapies for those disorders.</p>
</abstract>
<kwd-group>
<kwd>Glia</kwd>
<kwd>Excitatory amino acid transporter</kwd>
<kwd>Psychiatry</kwd>
<kwd>Affective disorders</kwd>
<kwd>Glutamate transporter</kwd>
<kwd>Glutamate</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p><bold>Core tip:</bold> Following release from the presynaptic neuron, the majority of glutamate within the human cortex is taken up into glia cells where it is converted into glutamine for recycling back into glutamate. Glutamate transporters excitatory amino acid transporter (EAAT) 1 and EAAT2 are predominantly localized in the glial plasma membrane, and are responsible for the majority of glutamate uptake within the human brain. Here we provide a comprehensive review of the unique regulation of EAAT1 and EAAT2 mRNA and protein in health and psychiatric disorder, and in response to medication use.</p>
<sec>
<title>GLUTAMATE AND EXCITOTOXICITY</title>
<p>Glutamate has long been recognized as the principal excitatory neurotransmitter of the mammalian brain[<xref ref-type="bibr" rid="B1">1</xref>]. It has been shown that glutamate concentration in the CNS extracellular space (approximately 0.6-2 μmol/L)[<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>] is comparatively lower than levels in cell cytoplasm (approximately 1-10 mmol/L)[<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. It is necessary for the level of extracellular glutamate to be kept low to allow for a high signal-to-noise ratio following the release of glutamate into the synapse and to prevent glutamate-mediated neuronal degeneration[<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>] as high levels of extracellular glutamate causes excitotoxicity and nerve damage[<xref ref-type="bibr" rid="B10">10</xref>]. The extracellular/intracellular glutamate gradient is at least partly maintained through the activity of Na<sup>+</sup>-dependent excitatory amino acid transporters (EAATs) which are in the membrane of pre-synaptic neurons and glia. Whilst glutamate uptake into astrocytes is also mediated by Na<sup>+</sup>-independent, chloride-dependent antiporters, this family of transporters appears to be responsible for less than 5% overall glutamate uptake[<xref ref-type="bibr" rid="B11">11</xref>]. Thus, this review will focus solely on the Na<sup>+</sup>-dependent EAAT family.</p>
</sec>
<sec>
<title>THE EAAT FAMILY: OVERVIEW</title>
<p>The EAAT family of transporters consists of five Na<sup>+</sup>-dependent high-affinity glutamate transporters termed EAAT1 [also known as solute carrier family 1 member 3 (SLC1A3)][<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], EAAT2/SLC1A2[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>], EAAT3/SLC1A1[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>], EAAT4/SLC1A6[<xref ref-type="bibr" rid="B16">16</xref>] and EAAT5/SLC1A7[<xref ref-type="bibr" rid="B17">17</xref>]. In this review, the accepted nomenclature of “EAAT” will be used in discussing data from both humans and other mammalians. These subtypes are quite differentiated - EAAT1, EAAT2 and EAAT3 only share 51%-55% amino acid sequence homology[<xref ref-type="bibr" rid="B18">18</xref>].</p>
</sec>
<sec>
<title>THE EAAT FAMILY: FUNCTION</title>
<p>The functionality of the glutamate transporters reflects their coupling to the electrochemical potential gradients of Na<sup>+</sup>, K<sup>+</sup> and H<sup>+</sup>/OH<sup>-</sup>. Specifically, glutamate is co-transported across the plasma membrane 1:2-3 with Na<sup>+</sup> and 1:1 H<sup>+</sup> (or counter-transport of OH<sup>-</sup>) and counter-transported 1:1 with K<sup>+[4,19,20]</sup>. This ionic association provides a net positive charge to glutamate transport[<xref ref-type="bibr" rid="B20">20</xref>] however a relatively slow turnover rate of approximately 70 ms makes it unlikely that this electrogenic attribute contributes significantly to the electrochemical gradient of the cell[<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Furthermore, this slow turnover rate suggests that the transporters act first to buffer glutamate away from the synapse, and transport glutamate into glia at a slower rate. The quantity of charge transferred per molecule of glutamate is highly voltage dependant due to the existence of a thermodynamically uncoupled, transporter substrate-specific movement of chloride ions through the transporter[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. The ion- and voltage- dependant uptake of glutamate makes this process highly susceptible to changes in the immediate cellular environment and plasma membrane potential.</p>
</sec>
<sec>
<title>THE EAAT FAMILY: LOCALISATION</title>
<p>Some of the functional properties of the EAATs can be attributed to their differential localisation. EAAT3 and EAAT5 are exclusively neuron-specific[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B24">24</xref>], with EAAT5 expression restricted to neurons and Müller cells of the retina[<xref ref-type="bibr" rid="B17">17</xref>]. By contrast, EAAT1 and EAAT2 are predominantly localised on astrocytes and are highly expressed in the cerebellum and hippocampus, respectively[<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. EAAT1, EAAT2 and EAAT3 have been reported to make up approximately 20%, 80% and 1% of all cell-surface glutamate transporters in the adult rat hippocampus, respectively[<xref ref-type="bibr" rid="B24">24</xref>]. EAAT4 is found in Purkinje neurons of the cerebellum[<xref ref-type="bibr" rid="B28">28</xref>].</p>
</sec>
<sec>
<title>THE EAAT FAMILY: ROLE IN GLIAL METABOLISM OF GLUTAMATE</title>
<p>Glial metabolism of glutamate is now recognised as a major factor in the control of glutamatergic neurotransmission[<xref ref-type="bibr" rid="B9">9</xref>], as, following the release of glutamate from the pre-synaptic neuron, the majority of the neurotransmitter diffuses out of the synaptic cleft where it is taken up into glial cells[<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. This effectively means that the astrocytic EAATs play a significant role in controlling the extent of glutamatergic activation by preventing neurotransmitter spill-over into neighbouring synapses[<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B32">32</xref>].</p>
<p>Once taken up by astrocytes, glutamate is either converted to glutamine by the glia-specific glutamine synthetase (GS)[<xref ref-type="bibr" rid="B33">33</xref>], or converted to α-ketoglutarate (α-KG) (also known as 2-oxoglutarate) through oxidation by glutamate dehydrogenase (GLDH) or transamination by aspartate aminotransferase[<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. α-KG may then be converted to succinate with a by-production of ATP (Figure <xref ref-type="fig" rid="F1">1</xref>) as part of the tricarboxylic acid cycle[<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. The formation of glutamine - the predominant metabolic pathway for glutamate - is followed by the transport of glutamine to neurons where it undergoes synthesis back into glutamate <italic>via</italic> the enzyme glutaminase[<xref ref-type="bibr" rid="B36">36</xref>] (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The metabolic fate of glutamate in glia cells. Glutamate is released from the pre-synaptic neuron to induce activation of the post-synaptic neuron <italic>via</italic> GluR. Spill-over of excess glutamate from the synaptic cleft is prevented through uptake by glial glutamate transporters EAAT1 and EAAT2, following which glutamate is converted to glutamine by GS for recycling back into glutamate, or α-KG for entrance into the tricarboxylic acid cycle. AAT: Aspartate Aminotransferase; α-KG: Alpha ketoglutarate; EAAT1/2: Excitatory amino acid transporter 1 and 2; GLDH: Glutamate dehydrogenase; Gln: Glutamine; GLS: Glutamate synthase; GS: Glutamine synthase; Glu: Glutamate; GluR: Glutamate receptors; Na+: Sodium; K+: Potassium.</p>
</caption>
<graphic xlink:href="WJP-8-51-g001"></graphic>
</fig>
<p>It is now acknowledged that glutamate excitotoxicity can potentially lead to problems in CNS functioning[<xref ref-type="bibr" rid="B8">8</xref>]. Significantly, it is now being speculated that glutamatergic excitotoxicity may in part be due to a reduction in glutamate uptake by astrocytic glutamate transporters and subsequent conversion of glutamate to glutamine by GS. Such an hypothesis is supported by research showing that inhibition or antisense oligonucleotide-knockdown of astrocytic glutamate transporters EAAT1 and EAAT2 results in excitotoxic oligodendrocyte death and nerve damage[<xref ref-type="bibr" rid="B37">37</xref>]. Moreover, whilst glutamate is usually taken into astrocytes under physiological conditions, it has been suggested that Ca<sup>2+</sup>-dependent activation of select signalling molecules, intracellular increase in Na<sup>+</sup> and glutamate, ATP depletion or cell swelling can lead to glutamate release through EAAT transporter reversal/reverse uptake[<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Such an outcome represents another mechanism that can lead to glutamate excitotoxicity.</p>
</sec>
<sec>
<title>THE EAAT FAMILY: A FOCUS ON EAAT1 AND EAAT2</title>
<p>The focus of this review is the potential involvement of glutamate transporters in the aetiology of psychiatric disorders. At present, most evidence implicating glutamate transporters in the aetiologies of psychiatric disorders is from the study of EAAT1 and EAAT2. Hence the remainder of this review will focus on those two forms of glutamate transporters.</p>
<sec>
<title>EAAT1</title>
<p>The <italic>EAAT1</italic> gene has been localised to human chromosome 5p11-12[<xref ref-type="bibr" rid="B39">39</xref>] and 5p13[<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. <italic>EAAT1</italic> is highly expressed in the glial cells of the cerebellar Purkinje cell layer[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B42">42</xref>] and generally is expressed at higher levels in astrocytes and oligodendrocytes compared to microglia[<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>The <italic>EAAT1</italic> gene encodes a 59 kDa protein that undergoes glycosylation to produce native 64 kDa and 70 kDa glycoproteins[<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B46">46</xref>]. Post-translational modification of EAAT1 is developmentally regulated, with glycosylated EAAT1 increasing and non-glycosylated EAAT1 decreasing after birth[<xref ref-type="bibr" rid="B47">47</xref>]. Glycosylation does not affect EAAT1 transport activity, however research by Conradt et al[<xref ref-type="bibr" rid="B46">46</xref>] suggests that the addition of carbohydrates does impact EAAT1 homodimerisation. This is significant because it has been suggested that activation of astrocytes increases homodimerisation of EAAT1 and trafficking of the transporter to the plasma membrane[<xref ref-type="bibr" rid="B48">48</xref>]. In addition to homodimers, EAAT1 protein has shown potential to form homotrimers[<xref ref-type="bibr" rid="B49">49</xref>]. Moreover, it has been reported that cell-surface protein expression of EAAT1 is upregulated by exogenous glutamate[<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B52">52</xref>], a process suggested to be mediated through transporter activity[<xref ref-type="bibr" rid="B51">51</xref>] and/or ionotropic glutamate receptor signalling[<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. EAAT1 protein levels have also been reported as being downregulated by the group I metabotropic glutamate receptor (mGluR) agonist, DHPG, which selectively activates mGluR1 and 5, and upregulated by the group II mGluR agonist, DCG-IV, which activates mGluR 2 and 3[<xref ref-type="bibr" rid="B53">53</xref>]. Further work is therefore required to fully elucidate which glutamate receptors are critical in controlling levels of EAAT1 at the cell surface.</p>
<p>At the level of protein localisation, high levels of EAAT1 protein can be observed on rat astrocytic membranes opposed to synaptically dense regions of the CNS and at higher levels on astrocytes facing capillaries, pia mater or stem dendrites[<xref ref-type="bibr" rid="B27">27</xref>]. Although predominantly a glial transporter, EAAT1 protein has also been detected in deep cerebellar rat neurons and transient protein expression of EAAT1 has been observed in cultured rat embryonic hippocampal neurons[<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B54">54</xref>]. Rat neuronal EAAT1 protein expression appears to be restricted to perinuclear localizations, in particular the Golgi apparatus and associated vesicles[<xref ref-type="bibr" rid="B26">26</xref>]. Soluble factors secreted from astrocytes appear to induce the repression of neuronal protein expression of EAAT1[<xref ref-type="bibr" rid="B55">55</xref>], which supports the aforementioned lack of EAAT1 protein at the neuronal cell surface. It is possible that, at least in the adult brain, neuronal EAAT1 is redundant, and may be upregulated where there is an inadequate presence of EAAT1-expressing astroglia.</p>
<p>The <italic>EAAT1</italic> gene is expressed in its full length coding sequence of 10 exons[<xref ref-type="bibr" rid="B39">39</xref>] and as three splice variants which encode shorter protein isoforms known as EAAT1a, EAAT1b and EAAT1c.</p>
<p>EAAT1a lacks exon 3 - which ordinarily encodes the first and second transmembrane domain and the first extracellular loop[<xref ref-type="bibr" rid="B45">45</xref>] - and has been detected in rat brain and retina[<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B56">56</xref>]. Significantly, it has been proposed that the splicing of exon 3 may reverse the orientation of EAAT1a within the membrane, and therefore the direction of glutamate transport[<xref ref-type="bibr" rid="B45">45</xref>]. EAAT1a has been shown to be predominantly expressed within internal vesicles, rather than on the cell membrane, in an osteocyte cell line[<xref ref-type="bibr" rid="B57">57</xref>]. Interestingly, an unglycosylated variant of EAAT1a protein has also been detected in rat brain[<xref ref-type="bibr" rid="B45">45</xref>]; as glycosylation has previously been associated with trafficking of EAAT1 to the cell surface, this may explain the localization of EAAT1a to internal vesicles.</p>
<p>mRNA for EAAT1b, which lacks exon 9[<xref ref-type="bibr" rid="B58">58</xref>], has been detected in both human grey matter and axonal tracts at levels that are 10%-20% that of the full length EAAT1[<xref ref-type="bibr" rid="B58">58</xref>]. EAAT1b localization has been associated with the endoplasmic reticulum[<xref ref-type="bibr" rid="B58">58</xref>], intracellular inclusions and the plasma membrane[<xref ref-type="bibr" rid="B59">59</xref>], where it appears to have no functional glutamate uptake activity[<xref ref-type="bibr" rid="B58">58</xref>]. Rather, it has been suggested that EAAT1b negatively regulates levels of full-length EAAT1 at the cell surface by preventing the insertion of the latter into the plasma membrane[<xref ref-type="bibr" rid="B58">58</xref>], possibly by interacting directly with full length EAAT1. EAAT1b appears to be particularly localised to cortical neurons[<xref ref-type="bibr" rid="B59">59</xref>] where it is suggested to play a role in preventing ectopic neuronal expression of EAAT1. Immunoperoxidase-labelling of EAAT1b was associated with the plasma membrane for morphologically healthy neurons and in punctate intracellular inclusions of neurons that appeared degenerate[<xref ref-type="bibr" rid="B59">59</xref>]. Furthermore, EAAT1b expression was increased in neuronal populations - and to a lesser extent astrocytes - that were subject to hypoxia, in histologically degenerate brain regions which also displayed a downregulation of glial EAAT1[<xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>EAAT1c mRNA, which lacks exon 5 and 6 of the full coding sequence, has been detected in astrocytes and oligodendrocytes of the human cortex, retina and optic nerve, as well as pig forebrain, midbrain, hindbrain and cerebellum[<xref ref-type="bibr" rid="B61">61</xref>]. The approximately 47 kDa glia-specific EAAT1c protein has been shown to have an intracellular perinuclear localization, with rapid redistribution to the cell surface following astrocytic stimulation[<xref ref-type="bibr" rid="B61">61</xref>]. Furthermore, EAAT1c does not undergo glycosylation[<xref ref-type="bibr" rid="B61">61</xref>]. Unfortunately the only study to examine EAAT1c was not able to determine its function, with the two most likely (default) candidates remaining as a regulator of full length EAAT1 cell surface expression, or as a <italic>bona fide</italic> transporter trafficked to the cell surface under appropriate conditions.</p>
</sec>
<sec>
<title>EAAT2</title>
<p>The EAAT2 gene is localized within human cytogenetic bands 11p12-13[<xref ref-type="bibr" rid="B62">62</xref>], and is responsible for the majority of glutamate uptake within the EAAT family (see[<xref ref-type="bibr" rid="B63">63</xref>] for review). EAAT2 expression appears to be restricted to the brain and placenta in humans[<xref ref-type="bibr" rid="B13">13</xref>] and has also been detected in cultured hippocampal neurons from rat embryo[<xref ref-type="bibr" rid="B64">64</xref>]. The mRNA expression of EAAT2 was found to be greater in cultured rat oligodendrocytes than astrocytes or microglia[<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>While EAAT2 protein expression has an overall homogenous brain distribution, it predominates across the forebrain with a particular focus in the hippocampus[<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>]. EAAT2 appears to be a predominantly glial glutamate transporter, with up to 80% of EAAT2 protein detected in glia plasma membrane, 6% localized to plasma membrane of pre-synaptic neurons and 8% to the axonal plasma membrane in the stratum radiatum of the rat hippocampal subregion CA1[<xref ref-type="bibr" rid="B67">67</xref>]. In line with the detection of EAAT2 mRNA[<xref ref-type="bibr" rid="B64">64</xref>], EAAT2 protein expression has similarly been recorded in cultured rat embryonic hippocampal neurons[<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B64">64</xref>]. Like EAAT1, EAAT2 protein undergoes glycosylation, which produces a 5-15 kDa shift in molecular weight[<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B68">68</xref>] and mediates its cell surface expression[<xref ref-type="bibr" rid="B68">68</xref>]. EAAT2 also exists in the plasma membrane as a multimer, with the potential to form dimers and trimers[<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B69">69</xref>].</p>
<p>EAAT2 would seem to have a complex role in development as it is transiently detected in neurons throughout ovine forebrain and cerebellum at 71 d gestation, and lost by 136 d gestation[<xref ref-type="bibr" rid="B70">70</xref>]. In addition, EAAT2 and glial fibrillary acidic protein (GFAP) have been reported to not be expressed by the same cells at 71 d ovine gestation but showed region-specific colocalization by 136 d gestation[<xref ref-type="bibr" rid="B70">70</xref>]. A similar transition from prenatal axonal pathways to astrocytic EAAT2 protein expression was also seen in rat[<xref ref-type="bibr" rid="B47">47</xref>]. Interestingly, it appears as if neuronal soluble factors may be required for proper expression of EAAT2 in neighbouring astrocytes[<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B71">71</xref>] with EAAT2 protein levels quantitatively higher in the synaptically dense regions of glial cells[<xref ref-type="bibr" rid="B27">27</xref>].</p>
<p>The human <italic>EAAT2</italic> gene consists of 11 exons[<xref ref-type="bibr" rid="B72">72</xref>]. Two functional splice variants of EAAT2, termed EAAT2b and EAAT2c, contain unique C-terminal domains and have been detected in rat brain (EAAT2b) and retina (EAAT2c)[<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. Additional splice variants which share the C-terminals of EAAT2 and EAAT2b, but have a unique N-terminal domain, have also been detected in mouse and rat liver and referred to as mGLT-1A/rGLT-1A and mGLT-1B, respectively[<xref ref-type="bibr" rid="B75">75</xref>] (see[<xref ref-type="bibr" rid="B74">74</xref>] for a comparison of amino acid terminal sequences). While the unique N-terminals has been proposed to regulate tissue-specific expression, the function of the differing C-terminal of mGLT-1A and mGLT-1B is less clear - the authors propose that it may be related to the retention time of the transporter in the plasma membrane[<xref ref-type="bibr" rid="B75">75</xref>]. As mGLT-1A/rGLT-1A and mGLT-1B are localized to the liver[<xref ref-type="bibr" rid="B75">75</xref>], they will not be discussed further in this review. Rather, further evidence for the role of the C-terminus can be presented using data on rat EAAT2b, which will be discussed in the following paragraph.</p>
<p>Full length EAAT2 (commonly referred to as EAAT2a) expression is about 25-fold and 10-fold higher than EAAT2b in human and rat brain, respectively[<xref ref-type="bibr" rid="B76">76</xref>]. EAAT2b protein is similarly found in glia, localized close to or within the plasma membrane[<xref ref-type="bibr" rid="B77">77</xref>-<xref ref-type="bibr" rid="B79">79</xref>], however transcript and protein have also been detected in neurons[<xref ref-type="bibr" rid="B78">78</xref>]. While EAAT2 is constitutively trafficked to the cell surface membrane, localization of EAAT2b is mediated through its C-terminal, which is predicted to interact with the postsynaptic density-95/Discs large/zona occludens-1 (PDZ) domain-containing protein disks large homolog-1 (DLG1)[<xref ref-type="bibr" rid="B80">80</xref>]. The interaction between EAAT2b and DLG1 is itself regulated through AMPA-associated intracellular calcium levels, with exogenous glutamate resulting in dissociation of EAAT2b and DLG1 and subsequent internalization of EAAT2b[<xref ref-type="bibr" rid="B80">80</xref>]. EAAT2b also coimmunoprecipitates with the excitatory postsynaptic density scaffolding protein, PSD-95, as well as the ionotropic N-methyl-D-aspartate receptor (NMDAR), both found within the postsynaptic neuron[<xref ref-type="bibr" rid="B81">81</xref>]. Significantly, EAAT2 has also been detected in these protein complexes, through the indirect formation of a hetero-oligomer with EAAT2b[<xref ref-type="bibr" rid="B81">81</xref>]. This suggests that EAAT2b may assist in conditional neuronal cell-sur-face expression of EAAT2. EAAT2b represented 6% of total rat hippocampal EAAT2 variants at 8 wk of age, compared to EAAT2 at 90%, whereas the equally functional EAAT2c sits at just 1%[<xref ref-type="bibr" rid="B77">77</xref>].</p>
<p>EAAT2c is made up of exons 1-10 from the EAAT2 transcript plus a unique eleventh exon and C-terminus spliced from intron 10 - thereby losing the original eleventh exon from EAAT2 - similarly contains a PDZ-binding domain and is pre-synaptically expressed in the rat and human retina[<xref ref-type="bibr" rid="B74">74</xref>].</p>
<p>Aberrant EAAT2 splice variants which skip exons have also been discovered: In particular, EAAT2 exon7skipping and EAAT2 exon9skipping lack glutamate transport functionality and must form multimers with functional EAAT2 or EAAT2b (see[<xref ref-type="bibr" rid="B82">82</xref>] for review). These splice variants add another layer of complexity to what has been considered a predominantly astrocytic glutamate transporter.</p>
</sec>
<sec>
<title>EAAT1 vs EAAT2: A summary</title>
<p>Despite belonging to the same family of transporters, sharing 52% amino acid identity[<xref ref-type="bibr" rid="B18">18</xref>] and being localized within the same astrocytic plasma membrane[<xref ref-type="bibr" rid="B49">49</xref>], EAAT1 and EAAT2 display many differences in their functionality. EAAT1 protein levels have been shown to function approximately 6 times slower than EAAT2, and be expressed at a level approximately 6 times higher in the adult rat cerebellar molecular layer[<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B65">65</xref>]. On the other hand, EAAT2 protein levels are upwards of 4 times higher than EAAT1 in the adult murine hippocampus[<xref ref-type="bibr" rid="B65">65</xref>]. Furthermore, unlike EAAT1, cell-surface protein expression of EAAT2 appears unaffected by exogenous glutamate levels but rather, is regulated by neuronal soluble factors[<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B52">52</xref>]. Finally, within the EAAT family, only EAAT2 can be competitively inhibited by kainic acid (KA) and dihydrokainic acid (DHK)[<xref ref-type="bibr" rid="B13">13</xref>]. Conversely, KA has been shown to increase EAAT1 protein levels[<xref ref-type="bibr" rid="B50">50</xref>]. It is possible that this increase in EAAT1 protein in response to KA is a homeostatic mechanism, counterbalancing for the inhibition of EAAT2.</p>
<p>The fact that EAAT1 and EAAT2, and their functionally distinct splice variants, may be differentially regulated by internal and external factors presents us with two distinct transporters that are part of a system that is highly responsive to cellular physiology. In the following paragraphs, we will present the current knowledge surrounding EAAT1 and EAAT2 in psychiatric illness, as well as their responsiveness to medication and potential as drug targets (refer to Table <xref ref-type="table" rid="T1">1</xref> for a summary).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>The role of EAAT 1 and 2 in psychiatric disorder and medication use</p>
</caption>
<table frame="hsides" rules="groups">
<tbody align="center">
<tr>
<td align="left" colspan="1" rowspan="19">EAAT1</td>
<td colspan="2" rowspan="1">Genetic studies</td>
</tr>
<tr>
<td colspan="1" rowspan="2">BD</td>
<td colspan="1" rowspan="1">SNP rs2731880 T/T genotype associated with worse working memory and selective attention during a depressive episode[<xref ref-type="bibr" rid="B102">102</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SNP rs2731880 T/T genotype increased negative fMRI BOLD coupling between the amygdala and AnCg[<xref ref-type="bibr" rid="B103">103</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Scz</td>
<td colspan="1" rowspan="1">SNP rs2731880 T/T genotype associated with worse executive function, verbal fluency and verbal memory[<xref ref-type="bibr" rid="B104">104</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">No association between EAAT1 SNPs rs1428973, rs2033267, rs426040, rs4869684, rs1544795, rs3776585, rs962686, rs2303716, rs3776586, rs1049524, rs1529461 and Scz[<xref ref-type="bibr" rid="B112">112</xref>]</td>
</tr>
<tr>
<td colspan="2" rowspan="1">mRNA studies</td>
</tr>
<tr>
<td colspan="1" rowspan="2">MDD</td>
<td colspan="1" rowspan="1">↓Lower levels in the DLPFC[<xref ref-type="bibr" rid="B83">83</xref>], AnCg[<xref ref-type="bibr" rid="B83">83</xref>], locus coeruleus[<xref ref-type="bibr" rid="B105">105</xref>] and hippocampus[<xref ref-type="bibr" rid="B106">106</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Higher cortical levels in suicide completers with a MDD diagnosis compared to those without a diagnosis[<xref ref-type="bibr" rid="B118">118</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="3">Scz</td>
<td colspan="1" rowspan="1">↑Higher mRNA in the cerebellar vermis[<xref ref-type="bibr" rid="B113">113</xref>], AnCg[<xref ref-type="bibr" rid="B114">114</xref>], thalamus[<xref ref-type="bibr" rid="B115">115</xref>] and prefrontal cortex[<xref ref-type="bibr" rid="B116">116</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">→No change in the DLPFC or primary visual cortex[<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B114">114</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Lower levels in the prefrontal cortex of subjects who completed suicide compared to those who did not[<xref ref-type="bibr" rid="B117">117</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Medication use</td>
<td colspan="1" rowspan="1">↑Haloperidol has been associated with an increase in EAAT1 mRNA in the thalamic medial dorsal nucleus[<xref ref-type="bibr" rid="B121">121</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Chronic sodium valproate resulted in an upregulation of EAAT1 mRNA in chick cerebellar BGC culture[<xref ref-type="bibr" rid="B110">110</xref>]</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Protein studies</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Scz</td>
<td colspan="1" rowspan="1">↓Decreased in the prefrontal cortex[<xref ref-type="bibr" rid="B114">114</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓N-glycosylation of EAAT1 monomer was decreased in the AnCg[<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B119">119</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PTSD</td>
<td colspan="1" rowspan="1">↓Hippocampal EAAT1 protein was lower in a single prolonged stress (SPS) rat model of PTSD[<xref ref-type="bibr" rid="B108">108</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Medication use</td>
<td colspan="1" rowspan="1">→Clozapine did not affect EAAT1 protein levels in rat[<xref ref-type="bibr" rid="B113">113</xref>,<xref ref-type="bibr" rid="B122">122</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Chronic sodium valproate resulted in an upregulation of EAAT1 protein in rat hippocampus and chick cerebellar BGC culture[<xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B110">110</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="25">EAAT2</td>
<td colspan="2" rowspan="1">Genetic studies</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Scz</td>
<td colspan="1" rowspan="1">SNP rs4354668 G/G associated with poorer working memory performance[<xref ref-type="bibr" rid="B104">104</xref>,<xref ref-type="bibr" rid="B138">138</xref>] and a reduction in frontal grey matter[<xref ref-type="bibr" rid="B139">139</xref>]</td>
</tr>
<tr>
<td colspan="2" rowspan="1">mRNA studies</td>
</tr>
<tr>
<td colspan="1" rowspan="3">MDD</td>
<td colspan="1" rowspan="1">↓Lower levels in DLPFC and AnCg[<xref ref-type="bibr" rid="B83">83</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Higher levels in subjects who had completed suicide without a diagnosis of MDD compared to those with a diagnosis[<xref ref-type="bibr" rid="B118">118</xref>,<xref ref-type="bibr" rid="B127">127</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Lower levels in the hippocampus, cerebral cortex and striatum of a rat model of depression[<xref ref-type="bibr" rid="B128">128</xref>,<xref ref-type="bibr" rid="B129">129</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="3">Scz</td>
<td colspan="1" rowspan="1">↓Lower levels in the parahippocampal gyrus[<xref ref-type="bibr" rid="B140">140</xref>] and prefrontal cortex[<xref ref-type="bibr" rid="B141">141</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Higher levels in the thalamus[<xref ref-type="bibr" rid="B115">115</xref>] and prefrontal cortex[<xref ref-type="bibr" rid="B142">142</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">→No change in EAAT2 or EAAT2b mRNA in the DLPFC or primary visual cortex[<xref ref-type="bibr" rid="B76">76</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="7">Medication use</td>
<td colspan="1" rowspan="1">↓Clozapine decreased levels in hippocampal CA1, parietal temporal, frontal and cingulate cortical[<xref ref-type="bibr" rid="B144">144</xref>], and striatal[<xref ref-type="bibr" rid="B145">145</xref>] brain regions of male Sprague-Dawley rats</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Haloperidol decreased frontal and cingulate cortical[<xref ref-type="bibr" rid="B144">144</xref>], as well as striatal[<xref ref-type="bibr" rid="B145">145</xref>], EAAT2 expression in rat</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Levels were higher in untreated subjects with Scz than in those prescribed typical or atypical antipsychotics[<xref ref-type="bibr" rid="B142">142</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Increased levels caused by chronic stress were normalised by tianeptine treatment in rat[<xref ref-type="bibr" rid="B130">130</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Increased hippocampal levels caused by stress were normalised by lithium administration in rat[<xref ref-type="bibr" rid="B137">137</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Fluoxetine increased rat hippocampal and cortical levels[<xref ref-type="bibr" rid="B136">136</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Tranylcypromine increased levels in rat amygdala[<xref ref-type="bibr" rid="B136">136</xref>]</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Protein studies</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Scz</td>
<td colspan="1" rowspan="1">↓ N-glycosylation of EAAT2 multimer was lower in the DLPFC[<xref ref-type="bibr" rid="B119">119</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">↑ EAAT2b increased in extrasynaptic membrane/cytosol fractions from the DLPFC[<xref ref-type="bibr" rid="B143">143</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">PTSD</td>
<td colspan="1" rowspan="1">↓Hippocampal EAAT2 protein was lower in the single prolonged stress (SPS) rat model of PTSD[<xref ref-type="bibr" rid="B108">108</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="5">Medication use</td>
<td colspan="1" rowspan="1">↓Clozapine decreased protein levels in astrocyte culture[<xref ref-type="bibr" rid="B147">147</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Clozapine reduced protein levels in the cerebral cortex of adult rats[<xref ref-type="bibr" rid="B146">146</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↓Increased levels caused by chronic stress were normalised by tianeptine treatment in rat[<xref ref-type="bibr" rid="B130">130</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">→Increases in EAAT2b protein caused by chronic stress were unaffected by tianeptine treatment in rat[<xref ref-type="bibr" rid="B130">130</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">↑Chronic sodium valproate increased hippocampal EAAT2 protein in rat[<xref ref-type="bibr" rid="B109">109</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>All research refers to human studies unless explicitly stated otherwise. References numbered as they are in the Reference section. ↑: Increase; ↓: Decrease; →: No change; AnCg: Anterior cingulate cortex; BGC: Bergmann glia cell; DLPFC: Dorsolateral prefrontal cortex; BD: Bipolar disorders; BOLD: Blood-oxygen dependent contrast imaging; fMRI: Functional magnetic resonance imaging; MDD: Major depressive disorders; PTSD: Post-traumatic stress disorder; Scz: Schizophrenia.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>EAATS IN PSYCHIATRIC ILLNESS</title>
<p>Glial dysfunction has been implicated in a range of psychiatric illnesses, including major depressive disorders (MDD)[<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B84">84</xref>], schizophrenia[<xref ref-type="bibr" rid="B85">85</xref>], bipolar disorders (BD)[<xref ref-type="bibr" rid="B86">86</xref>] and post-traumatic stress disorder (PTSD)[<xref ref-type="bibr" rid="B87">87</xref>]. Glia dysfunction has also been associated with suicide completion[<xref ref-type="bibr" rid="B88">88</xref>,<xref ref-type="bibr" rid="B89">89</xref>]. The association between the glutamatergic neurotransmitter system and psychiatric illness is not new[<xref ref-type="bibr" rid="B90">90</xref>,<xref ref-type="bibr" rid="B91">91</xref>]; originally based on the observation that phenylcyclidine (PCP), and later ketamine - both NMDA receptor antagonists - could induce schizophrenia-like positive and negative symptoms, as well as cognitive impairment[<xref ref-type="bibr" rid="B92">92</xref>-<xref ref-type="bibr" rid="B94">94</xref>]. While glutamatergic dysfunction is also hypothesized to be involved in other neurodevelopmental disorders such as autism[<xref ref-type="bibr" rid="B95">95</xref>] and attention deficit hyperactivity disorder[<xref ref-type="bibr" rid="B96">96</xref>,<xref ref-type="bibr" rid="B97">97</xref>], neurodegenerative disorders such as dementia[<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>], substance abuse/addiction[<xref ref-type="bibr" rid="B100">100</xref>] and chronic pain[<xref ref-type="bibr" rid="B101">101</xref>] (the latter two referenced reviews are written with a focus on EAATs), these topics are outside the scope of the current review.</p>
<sec>
<title>EAAT1 in psychiatric illness</title>
<p>The rs2731880 (C/T) single nucleotide polymorphism (SNP) of <italic>EAAT1</italic> has been associated with deficits in working memory and selective attention in patients with Type 1 bipolar disorder during a depressive episode, with T/T homozygotes displaying significantly worse performance[<xref ref-type="bibr" rid="B102">102</xref>]. Furthermore, bipolar disorder patients with the rs2731880 T/T genotype have displayed an overall negative correlation between amygdala and subgenual anterior cingulate cortex (AnCg) functional magnetic resonance imaging (fMRI) blood-oxygen-level dependent (BOLD) contrast imaging during a task which involved the processing of emotional or neutral faces, whereas in carriers of the C allele the coupling was absent[<xref ref-type="bibr" rid="B103">103</xref>]. SNP rs2731880 is a putative functional polymorphism within the promoter region of <italic>EAAT1</italic>, with the T/T genotype proposed to be associated with lower expression[<xref ref-type="bibr" rid="B104">104</xref>]. In support of the hypothesis that lower EAAT1 expression is associated with affective disorders, lower levels of EAAT1 mRNA have been reported in the human dorsolateral prefrontal cortex (DLPFC)[<xref ref-type="bibr" rid="B83">83</xref>], AnCg[<xref ref-type="bibr" rid="B83">83</xref>], locus coeruleus[<xref ref-type="bibr" rid="B105">105</xref>] and hippocampus[<xref ref-type="bibr" rid="B106">106</xref>] from subjects with MDD. Interestingly, Group II mGluR receptors - the agonists of which have been shown to upregulate EAAT1 protein levels[<xref ref-type="bibr" rid="B53">53</xref>] - are also decreased in MDD[<xref ref-type="bibr" rid="B107">107</xref>].</p>
<p>Furthermore, Feng et al[<xref ref-type="bibr" rid="B108">108</xref>] detected an increase in CSF glutamate levels and decrease in hippocampal EAAT1 protein levels in the single prolonged stress (SPS) rat model for PTSD. Interestingly, administration of fibroblast growth factor 2 (FGF2) alleviated the SPS-induced PTSD-like behaviour, promoted glutamate uptake and increased EAAT1 protein expression, thereby suggesting that astrocyte activation (and EAAT1 upregulation) may be advantageous in the treatment of PTSD[<xref ref-type="bibr" rid="B108">108</xref>].</p>
<p>Short-term sodium valproate treatment augmented EAAT1 translocation to the cell membrane, whereas prolonged or chronic sodium valproate treatment resulted in an upregulation of EAAT1 mRNA and protein levels, as well as glutamate transport and production of glutamine[<xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B110">110</xref>]. The ability of sodium valproate treatment to increase EAAT1 mRNA and protein levels, which are downregulated in affective disorders, contributes EAAT1 dynamics to an understanding of the medication’s effectiveness[<xref ref-type="bibr" rid="B111">111</xref>]. This is not surprising, given that sodium valproate is used to treat both epilepsy - a disorder of excitotoxicity - and bipolar disorders.</p>
<p>Carriers of the rs2731880 SNP T/T genotype with a diagnosis of schizophrenia performed worse in tests of executive function, verbal fluency and verbal memory than the C carrier group[<xref ref-type="bibr" rid="B104">104</xref>]. This association has overlap with cognitive performance of subjects with bipolar disorder I[<xref ref-type="bibr" rid="B102">102</xref>]. Furthermore, Deng et al[<xref ref-type="bibr" rid="B112">112</xref>] analysed 11 <italic>EAAT1</italic> SNPS - exclusive of rs2731880 - in a Japanese population and found no association between <italic>EAAT1</italic> genotype and schizophrenia. These genotypic association studies suggest that while there may exist a relationship between <italic>EAAT1</italic> genotype and cognition, particularly within the context of psychiatric disorder, it is not a susceptibility locus specific to either schizophrenia or bipolar disorders.</p>
<p>Levels of EAAT1 mRNA have been reported as higher in the cerebellar vermis[<xref ref-type="bibr" rid="B113">113</xref>], AnCg[<xref ref-type="bibr" rid="B114">114</xref>], thalamus[<xref ref-type="bibr" rid="B115">115</xref>] and prefrontal cortex[<xref ref-type="bibr" rid="B116">116</xref>] of subjects with schizophrenia. In comparison, other studies have found no changes in EAAT1 expression in the DLPFC[<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B114">114</xref>] or primary visual cortex[<xref ref-type="bibr" rid="B76">76</xref>] of subjects with schizophrenia. However, lower levels of EAAT1 mRNA were found in the prefrontal cortices of subjects with schizophrenia who completed suicide relative to those who did not[<xref ref-type="bibr" rid="B117">117</xref>], a confounding factor that many studies have not taken into consideration. Conversely, it has also been reported that EAAT1 mRNA levels were higher in the cortex of suicide completers without a prior diagnosis of MDD but not those with the diagnosis[<xref ref-type="bibr" rid="B118">118</xref>]. These data suggest complex expression x diagnoses x suicide factors that need to be considered when contemplating the role of EAAT1 in psychiatric disorders. Finally, monomeric EAAT1 protein expression was decreased in the DLPFC of elderly subjects with schizophrenia[<xref ref-type="bibr" rid="B114">114</xref>], while N-glycosylation of EAAT1 protein monomer was decreased in the AnCg[<xref ref-type="bibr" rid="B119">119</xref>]. Animal models have shown that <italic>EAAT1</italic> knock-out mice displayed locomotor hyperactivity in response to a novel environment which was exacerbated by NMDAR antagonists – two phenotypes considered to be relevant models for the positive symptoms of schizophrenia[<xref ref-type="bibr" rid="B120">120</xref>].</p>
<p>Interestingly, the locomotor hyperactivity in <italic>EAAT1</italic> knock-out mice could be normalised by treatment with haloperidol or the mGluR 2/3 agonist LY379268[<xref ref-type="bibr" rid="B120">120</xref>]. As EAAT1 protein levels have previously been shown to increase with administration of the mGluR 2/3 agonist DCG-IV[<xref ref-type="bibr" rid="B53">53</xref>], the data in <italic>EAAT1</italic> knockout mice suggests that activation of mGluR 2/3 may impact on a function downstream of glial glutamate uptake. Haloperidol has similarly been associated with an increase in EAAT1 RNA in the thalamic medial dorsal nucleus in subjects with schizophrenia[<xref ref-type="bibr" rid="B121">121</xref>]. On the other hand, administration of clozapine did not appear to affect EAAT1 protein levels in treated Sprague-Dawley rats[<xref ref-type="bibr" rid="B113">113</xref>,<xref ref-type="bibr" rid="B122">122</xref>], possibly due to the fact that clozapine, but not haloperidol, increases NMDAR-mediated neurotransmission through synaptobrevin-associated glial release of glutamate and <sc>D</sc>-serine[<xref ref-type="bibr" rid="B123">123</xref>]. If clozapine administration induces glutamate release from glia, it seems unlikely that glia would simultaneously increase a means to re-uptake glutamate. In conclusion, it appears that while the actions of haloperidol indirectly affect EAAT1 expression, clozapine seems to act through an alternative mechanism that is unrelated to EAAT1.</p>
<p>In summary, current data suggest an overall decrease in EAAT1 mRNA in affective disorders, while an increase in EAAT1 mRNA and decrease in EAAT1 protein is associated with schizophrenia; results which are further complicated by suicide completion and medication use. These factors must be taken into consideration when studying EAAT1, and the glutamatergic system as a whole, in terms of treatment for psychiatric illness.</p>
</sec>
<sec>
<title>EAAT2 in psychiatric illness</title>
<p>EAAT2 translation may be regulated by a large range of molecules, including the stress-related glucocorticoids[<xref ref-type="bibr" rid="B124">124</xref>-<xref ref-type="bibr" rid="B126">126</xref>], creating a putative link between EAAT2 protein levels and stress-induced biological responses. To date, one study has recorded a lower levels of EAAT2 mRNA in the DLPFC and AnCg of subjects with MDD[<xref ref-type="bibr" rid="B83">83</xref>]. Interestingly, as with EAAT1, levels of EAAT2 mRNA were higher in the cortex of subjects who had completed suicide without a history of MDD, but not in those with a prior diagnosis[<xref ref-type="bibr" rid="B118">118</xref>,<xref ref-type="bibr" rid="B127">127</xref>]. EAAT2 mRNA was also lower in the hippocampus and cerebral cortex of learned helplessness rats – an established animal model of depression[<xref ref-type="bibr" rid="B128">128</xref>] and in the hippocampus, striatum, and frontal cortex of prenatally, restraint- stressed juvenile rats displaying increased behavioural despair[<xref ref-type="bibr" rid="B129">129</xref>].</p>
<p>Hippocampal EAAT2 protein levels were also observed to be lower in a SPS rat model of PTSD, which, like EAAT1 protein levels, could be alleviated by treatment with FGF2[<xref ref-type="bibr" rid="B108">108</xref>]. Interestingly, a rat model of chronic stress produced upregulated EAAT2 mRNA and protein levels in the hippocampus[<xref ref-type="bibr" rid="B130">130</xref>], suggesting that EAAT2 regulation may respond differently to the type, duration and severity of stress stimuli. Finally, amygdala specific DHK-inhibition of EAAT2 activity in rat resulted in reduced social interaction – a behavioural phenotype that could be blocked by the NMDA receptor antagonist, AP5[<xref ref-type="bibr" rid="B131">131</xref>].</p>
<p>Cerebrospinal fluid glutamate levels have been reported as higher in patients with obsessive compulsive disorder (OCD)[<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B133">133</xref>]. To date however, an association between OCD and the glutamate transporters has only been proposed for the neuronal EAAT3, which is significantly less involved in glutamate uptake when compared to EAAT1 and EAAT2[<xref ref-type="bibr" rid="B134">134</xref>]. That said, astrocyte-specific inducible knockout of EAAT2 in adolescent - but not prenatal or adult - mice has been shown to result in glutamatergic hyperexcitability-related pathological repetitive self-grooming and tic-like head shakes[<xref ref-type="bibr" rid="B135">135</xref>]. Interestingly, these mice did not present with increased anxiety or social impairments[<xref ref-type="bibr" rid="B135">135</xref>].</p>
<p>It seems that the lower EAAT2 expression associated with depression and learned helplessness can be rescued by mood stabilizers. Chronic sodium valproate treatment increased EAAT2 protein levels in the rat hippocampus, but not other brain regions[<xref ref-type="bibr" rid="B109">109</xref>]. The antidepressant fluoxetine (class: SSRI) also produced rat hippocampal and cortical increases in EAAT2 expression, while tranylcypromine (class: monoamine oxidase inhibitor) resulted in an amygdala-specific increase[<xref ref-type="bibr" rid="B136">136</xref>]. In contrast to a depressive state, increases in EAAT2 mRNA and protein caused by chronic stress could be normalised by the antidepressant tianeptine in rat[<xref ref-type="bibr" rid="B130">130</xref>]. Interestingly, EAAT2b protein, but not mRNA, was also increased by chronic stress, however remained unaffected by tianeptine treatment[<xref ref-type="bibr" rid="B130">130</xref>]. A similar stress-induced increase in hippocampal EAAT2 mRNA expression was countered by food-based administration of lithium in rat[<xref ref-type="bibr" rid="B137">137</xref>]. This increase in EAAT2 expression in response to chronic stress lies in stark contrast to the previously mentioned decreases in EAAT2 expression associated with depression and learned helplessness, and suggests that EAAT2 is highly responsive to, or correlated with, different mood states.</p>
<p><italic>EAAT2</italic> SNP rs4354668 (T/G), located in the gene promoter region and associated with lower transport activity, has been correlated to cognitive dysfunction in schizophrenia, with the lower activity G allele linked to poorer working memory performance[<xref ref-type="bibr" rid="B104">104</xref>,<xref ref-type="bibr" rid="B138">138</xref>] and a reduction in frontal grey matter[<xref ref-type="bibr" rid="B139">139</xref>]. EAAT2 mRNA levels have been reported as lower in the parahippocampal gyrus -but not other hippocampal regions[<xref ref-type="bibr" rid="B140">140</xref>] and prefrontal cortex[<xref ref-type="bibr" rid="B141">141</xref>], and higher in the thalamus of subjects with schizophrenia[<xref ref-type="bibr" rid="B115">115</xref>]. In contrast, Matute et al[<xref ref-type="bibr" rid="B142">142</xref>] found an increase in EAAT2 expression in the prefrontal cortex. Finally, Lauriat et al[<xref ref-type="bibr" rid="B76">76</xref>] found no change in EAAT2 or EAAT2b mRNA in the DLPFC or primary visual cortex of subjects with schizophrenia, however the authors acknowledge the potential masking effect of antipsychotics on their results. N-glycosylation of the EAAT2 multimer was reduced in the DLPFC from subjects with schizophrenia[<xref ref-type="bibr" rid="B119">119</xref>], which may be associated with ER retention and reduced trafficking of EAAT2 to the plasma membrane[<xref ref-type="bibr" rid="B68">68</xref>]. The splice variant EAAT2b was increased in extra-synaptic membrane/cytosol post-mortem fractions from the DLPFC of subjects with schizophrenia[<xref ref-type="bibr" rid="B143">143</xref>]. As EAAT2b cell-surface expression is internalised in response to increases in intracellular calcium[<xref ref-type="bibr" rid="B80">80</xref>], it is possible that the elevated cytosolic localization of EAAT2b is a countermeasure to excitotoxicity.</p>
<p>Clozapine treatment has been reported to decrease EAAT2 expression in hippocampal CA1, parietal temporal, frontal and cingulate cortical[<xref ref-type="bibr" rid="B144">144</xref>], and striatal[<xref ref-type="bibr" rid="B145">145</xref>] brain regions of male Sprague-Dawley rats. EAAT2 protein levels and glutamate uptake were similarly reduced in the cerebral cortex of clozapine-treated adult rats with an accompanying increase in extracellular glutamate[<xref ref-type="bibr" rid="B146">146</xref>]. Clozapine also induced a decrease in EAAT2 protein in astrocyte culture, which was accompanied by a reduction in glutamate uptake[<xref ref-type="bibr" rid="B147">147</xref>]. This response to clozapine, which contrasts with the lack of effect that clozapine had on EAAT1 expression (discussed earlier in this review), suggests once again that the two EAAT subtypes are intrinsically different. Haloperidol similarly decreased frontal and cingulate cortical[<xref ref-type="bibr" rid="B144">144</xref>], as well as striatal[<xref ref-type="bibr" rid="B145">145</xref>], EAAT2 expression in rat. Matute and colleagues have provided support to the argument that antipsychotic drug treatment can affect EAAT2 expression by showing the higher levels of EAAT2 mRNA in the prefrontal cortex of untreated subjects with schizophrenia were not detectable in those with the disorder who had received typical or atypical antipsychotics[<xref ref-type="bibr" rid="B142">142</xref>].</p>
</sec>
</sec>
<sec>
<title>CONCLUSION</title>
<p>Given the differential expression of EAAT1 and EAAT2 throughout brain development[<xref ref-type="bibr" rid="B47">47</xref>] and their importance in normal brain development[<xref ref-type="bibr" rid="B148">148</xref>], it is not surprisingly that abnormal levels of these glutamate transporters have been found in the pathophysiology of psychiatric illness. It is imperative, however, that the subtype splice variants and glycosylation states be taken into consideration when researching the EAATs, as their unique attributes make them just as susceptible to disorder. The ability to analysis EAAT dynamics in a pre-mortem setting will assist in understanding the cause for their dysregulation and through that, the glutamatergic role in psychiatric disorder. Such information will allow for the prescription of medication with an understanding of how it may, or may not, affect the glutamatergic system. This review concludes with the contention that the EAAT family is dynamically regulated by a range of internal and external factors and offer a viable means to region-specific, subtype-specific therapeutic targets with the potential to respond to the immediate environment. However, a better understanding of the dynamic regulation of EAATs within the convoluted context of psychiatric disorder will be advantageous in advancing drug discovery.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="COI-statement">
<p>Conflict-of-interest statement: The authors declare no conflicts of interest for this article.</p>
</fn>
<fn>
<p>Manuscript source: Invited manuscript</p>
</fn>
<fn>
<p>Peer-review started: March 19, 2018</p>
</fn>
<fn>
<p>First decision: May 8, 2018</p>
</fn>
<fn>
<p>Article in press: June 9, 2018</p>
</fn>
<fn>
<p>Specialty type: Psychiatry</p>
</fn>
<fn>
<p>Country of origin: Australia</p>
</fn>
<fn>
<p>Peer-review report classification</p>
</fn>
<fn>
<p>Grade A (Excellent): 0</p>
</fn>
<fn>
<p>Grade B (Very good): B, B</p>
</fn>
<fn>
<p>Grade C (Good): C, C</p>
</fn>
<fn>
<p>Grade D (Fair): 0</p>
</fn>
<fn>
<p>Grade E (Poor): 0</p>
</fn>
<fn>
<p>P- Reviewer: Chakrabarti S, Hosak L, Pasquini M, Tcheremissine OV S- Editor: Ji FF L- Editor: A E- Editor: Tan WW</p>
</fn>
</fn-group>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meldrum</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Glutamate as a neurotransmitter in the brain: review of physiology and pathology</article-title>
<source/>J Nutr
          <year>2000</year>
<volume>130</volume>
<fpage>1007S</fpage>
<lpage>1015S</lpage>
<pub-id pub-id-type="pmid">10736372</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benveniste</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Drejer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Diemer</surname>
<given-names>NH</given-names>
</name>
</person-group>
<article-title>Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis</article-title>
<source/>J Neurochem
          <year>1984</year>
<volume>43</volume>
<fpage>1369</fpage>
<lpage>1374</lpage>
<pub-id pub-id-type="pmid">6149259</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Isacsson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hamberger</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus</article-title>
<source/>J Neurochem
          <year>1983</year>
<volume>40</volume>
<fpage>1314</fpage>
<lpage>1320</lpage>
<pub-id pub-id-type="pmid">6834062</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouvier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szatkowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Attwell</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The glial cell glutamate uptake carrier countertransports pH-changing anions</article-title>
<source/>Nature
          <year>1992</year>
<volume>360</volume>
<fpage>471</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">1448171</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erecińska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>IA</given-names>
</name>
</person-group>
<article-title>Metabolism and role of glutamate in mammalian brain</article-title>
<source/>Prog Neurobiol
          <year>1990</year>
<volume>35</volume>
<fpage>245</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">1980745</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lesk</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Free amino acids and related compounds in biopsies of human brain</article-title>
<source/>J Neurochem
          <year>1971</year>
<volume>18</volume>
<fpage>521</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="pmid">5559258</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Regional distribution of amino acids in human brain obtained at autopsy</article-title>
<source/>J Neurochem
          <year>1971</year>
<volume>18</volume>
<fpage>513</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="pmid">5559257</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Glutamate neurotoxicity and diseases of the nervous system</article-title>
<source/>Neuron
          <year>1988</year>
<volume>1</volume>
<fpage>623</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="pmid">2908446</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>Glutamate uptake</article-title>
<source/>Prog Neurobiol
          <year>2001</year>
<volume>65</volume>
<fpage>1</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">11369436</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Excitotoxic cell death</article-title>
<source/>J Neurobiol
          <year>1992</year>
<volume>23</volume>
<fpage>1261</fpage>
<lpage>1276</lpage>
<pub-id pub-id-type="pmid">1361523</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Astrocyte glutamate transport: review of properties, regulation, and physiological functions</article-title>
<source/>Glia
          <year>2000</year>
<volume>32</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">10975906</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storck</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stoffel</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1992</year>
<volume>89</volume>
<fpage>10955</fpage>
<lpage>10959</lpage>
<pub-id pub-id-type="pmid">1279699</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arriza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Fairman</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Wadiche</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex</article-title>
<source/>J Neurosci
          <year>1994</year>
<volume>14</volume>
<fpage>5559</fpage>
<lpage>5569</lpage>
<pub-id pub-id-type="pmid">7521911</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pines</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Bjørås</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bendahan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eide</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Koepsell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seeberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kanner</surname>
<given-names>BI</given-names>
</name>
</person-group>
<article-title>Cloning and expression of a rat brain L-glutamate transporter</article-title>
<source/>Nature
          <year>1992</year>
<volume>360</volume>
<fpage>464</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="pmid">1448170</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Primary structure and functional characterization of a high-affinity glutamate transporter</article-title>
<source/>Nature
          <year>1992</year>
<volume>360</volume>
<fpage>467</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="pmid">1280334</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fairman</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Vandenberg</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Arriza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>An excitatory amino-acid transporter with properties of a ligand-gated chloride channel</article-title>
<source/>Nature
          <year>1995</year>
<volume>375</volume>
<fpage>599</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="pmid">7791878</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arriza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Eliasof</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1997</year>
<volume>94</volume>
<fpage>4155</fpage>
<lpage>4160</lpage>
<pub-id pub-id-type="pmid">9108121</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Hediger</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>A new family of neurotransmitter transporters: the high-affinity glutamate transporters</article-title>
<source/>FASEB J
          <year>1993</year>
<volume>7</volume>
<fpage>1450</fpage>
<lpage>1459</lpage>
<pub-id pub-id-type="pmid">7903261</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stallcup</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Bulloch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baetge</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Coupled transport of glutamate and sodium in a cerebellar nerve cell line</article-title>
<source/>J Neurochem
          <year>1979</year>
<volume>32</volume>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">759585</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergles</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Jahr</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Synaptic activation of glutamate transporters in hippocampal astrocytes</article-title>
<source/>Neuron
          <year>1997</year>
<volume>19</volume>
<fpage>1297</fpage>
<lpage>1308</lpage>
<pub-id pub-id-type="pmid">9427252</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grewer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Electrogenic glutamate transporters in the CNS: molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling</article-title>
<source/>J Membr Biol
          <year>2005</year>
<volume>203</volume>
<fpage>1</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">15834685</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wadiche</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Arriza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Kinetics of a human glutamate transporter</article-title>
<source/>Neuron
          <year>1995</year>
<volume>14</volume>
<fpage>1019</fpage>
<lpage>1027</lpage>
<pub-id pub-id-type="pmid">7748550</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wadiche</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kavanaugh</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Ion fluxes associated with excitatory amino acid transport</article-title>
<source/>Neuron
          <year>1995</year>
<volume>15</volume>
<fpage>721</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">7546750</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmseth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dehnes</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Follin-Arbelet</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Grutle</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Mylonakou</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Plachez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Furness</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Bergles</surname>
<given-names>DE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS</article-title>
<source/>J Neurosci
          <year>2012</year>
<volume>32</volume>
<fpage>6000</fpage>
<lpage>6013</lpage>
<pub-id pub-id-type="pmid">22539860</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Asan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Püschel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kugler</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry</article-title>
<source/>J Neurosci
          <year>1997</year>
<volume>17</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">8987731</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Levey</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Dykes-Hoberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nash</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kuncl</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>Localization of neuronal and glial glutamate transporters</article-title>
<source/>Neuron
          <year>1994</year>
<volume>13</volume>
<fpage>713</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="pmid">7917301</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>van Lookeren Campagne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry</article-title>
<source/>Neuron
          <year>1995</year>
<volume>15</volume>
<fpage>711</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="pmid">7546749</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses</article-title>
<source/>Neuroreport
          <year>1996</year>
<volume>7</volume>
<fpage>2013</fpage>
<lpage>2017</lpage>
<pub-id pub-id-type="pmid">8905715</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Svenneby</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hertz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Uptake and metabolism of glutamate in astrocytes cultured from dissociated mouse brain hemispheres</article-title>
<source/>J Neurochem
          <year>1977</year>
<volume>29</volume>
<fpage>999</fpage>
<lpage>1005</lpage>
<pub-id pub-id-type="pmid">23414</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLennan</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The autoradiographic localization of L-[3h]glutamate in rat brain tissue</article-title>
<source/>Brain Res
          <year>1976</year>
<volume>115</volume>
<fpage>139</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="pmid">974737</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gundersen</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Shupliakov</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Brodin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Quantification of excitatory amino acid uptake at intact glutamatergic synapses by immunocytochemistry of exogenous D-aspartate</article-title>
<source/>J Neurosci
          <year>1995</year>
<volume>15</volume>
<fpage>4417</fpage>
<lpage>4428</lpage>
<pub-id pub-id-type="pmid">7790917</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergles</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Dzubay</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Jahr</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Glutamate transporter currents in bergmann glial cells follow the time course of extrasynaptic glutamate</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1997</year>
<volume>94</volume>
<fpage>14821</fpage>
<lpage>14825</lpage>
<pub-id pub-id-type="pmid">9405697</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Hernandez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Norenberg</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Glutamine synthetase: glial localization in brain</article-title>
<source/>Science
          <year>1977</year>
<volume>195</volume>
<fpage>1356</fpage>
<lpage>1358</lpage>
<pub-id pub-id-type="pmid">14400</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farinelli</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Nicklas</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Glutamate metabolism in rat cortical astrocyte cultures</article-title>
<source/>J Neurochem
          <year>1992</year>
<volume>58</volume>
<fpage>1905</fpage>
<lpage>1915</lpage>
<pub-id pub-id-type="pmid">1348525</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hertz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures</article-title>
<source/>J Neurochem
          <year>1982</year>
<volume>39</volume>
<fpage>954</fpage>
<lpage>960</lpage>
<pub-id pub-id-type="pmid">6126524</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bachelard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fonnum</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sonnewald</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate</article-title>
<source/>J Cereb Blood Flow Metab
          <year>1997</year>
<volume>17</volume>
<fpage>1230</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="pmid">9390655</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domercq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Etxebarria</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pérez-Samartín</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition</article-title>
<source/>Glia
          <year>2005</year>
<volume>52</volume>
<fpage>36</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">15892126</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatkowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barbour</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Attwell</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake</article-title>
<source/>Nature
          <year>1990</year>
<volume>348</volume>
<fpage>443</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="pmid">2247147</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoffel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Düker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lichter</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Human high affinity, Na(+)-dependent L-glutamate/L-aspartate transporter GLAST-1 (EAAT-1): gene structure and localization to chromosome 5p11-p12</article-title>
<source/>FEBS Lett
          <year>1996</year>
<volume>386</volume>
<fpage>189</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">8647279</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirschner</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Arriza</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Magenis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>The mouse and human excitatory amino acid transporter gene (EAAT1) maps to mouse chromosome 15 and a region of syntenic homology on human chromosome 5</article-title>
<source/>Genomics
          <year>1994</year>
<volume>22</volume>
<fpage>631</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="pmid">8001975</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Localization of the gene (SLC1A3) encoding human glutamate transporter (GluT-1) to 5p13 by fluorescence in situ hybridization</article-title>
<source/>Cytogenet Cell Genet
          <year>1995</year>
<volume>69</volume>
<fpage>209</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">7698014</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torp</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Babaie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bjørås</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seeberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>OP</given-names>
</name>
</person-group>
<article-title>Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study</article-title>
<source/>Eur J Neurosci
          <year>1994</year>
<volume>6</volume>
<fpage>936</fpage>
<lpage>942</lpage>
<pub-id pub-id-type="pmid">7952280</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kitanaka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suzumura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marunouchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Expression of glutamate transporters in cultured glial cells</article-title>
<source/>Neurosci Lett
          <year>1995</year>
<volume>188</volume>
<fpage>140</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">7792059</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stoffel</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>UDP galactose:ceramide galactosyltransferase and glutamate/aspartate transporter. Copurification, separation and characterization of the two glycoproteins</article-title>
<source/>Eur J Biochem
          <year>1995</year>
<volume>233</volume>
<fpage>947</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="pmid">8521863</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huggett</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vaughan-Thomas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain</article-title>
<source/>FEBS Lett
          <year>2000</year>
<volume>485</volume>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">11086157</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conradt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Storck</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stoffel</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Localization of N-glycosylation sites and functional role of the carbohydrate units of GLAST-1, a cloned rat brain L-glutamate/L-aspartate transporter</article-title>
<source/>Eur J Biochem
          <year>1995</year>
<volume>229</volume>
<fpage>682</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="pmid">7758463</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Glutamate transporter protein subtypes are expressed differentially during rat CNS development</article-title>
<source/>J Neurosci
          <year>1997</year>
<volume>17</volume>
<fpage>8363</fpage>
<lpage>8375</lpage>
<pub-id pub-id-type="pmid">9334410</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escartin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brouillet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gubellini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Trioulier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jacquard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smadja</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Knott</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Kerkerian-Le Goff</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Déglon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hantraye</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo</article-title>
<source/>J Neurosci
          <year>2006</year>
<volume>26</volume>
<fpage>5978</fpage>
<lpage>5989</lpage>
<pub-id pub-id-type="pmid">16738240</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haugeto</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ullensvang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Chaudhry</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Honoré</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>Brain glutamate transporter proteins form homomultimers</article-title>
<source/>J Biol Chem
          <year>1996</year>
<volume>271</volume>
<fpage>27715</fpage>
<lpage>27722</lpage>
<pub-id pub-id-type="pmid">8910364</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gegelashvili</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Civenni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Racagni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes</article-title>
<source/>Neuroreport
          <year>1996</year>
<volume>8</volume>
<fpage>261</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="pmid">9051792</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST</article-title>
<source/>J Neurosci
          <year>1999</year>
<volume>19</volume>
<fpage>10193</fpage>
<lpage>10200</lpage>
<pub-id pub-id-type="pmid">10575016</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gegelashvili</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia</article-title>
<source/>J Neurochem
          <year>1997</year>
<volume>69</volume>
<fpage>2612</fpage>
<lpage>2615</lpage>
<pub-id pub-id-type="pmid">9375696</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gegelashvili</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dehnes</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms</article-title>
<source/>Neurochem Int
          <year>2000</year>
<volume>37</volume>
<fpage>163</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">10812201</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plachez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Récasens</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture</article-title>
<source/>J Neurosci Res
          <year>2000</year>
<volume>59</volume>
<fpage>587</fpage>
<lpage>593</lpage>
<pub-id pub-id-type="pmid">10686586</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plachez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guiramand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Récasens</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Astrocytes repress the neuronal expression of GLAST and GLT glutamate transporters in cultured hippocampal neurons from embryonic rats</article-title>
<source/>Neurochem Int
          <year>2004</year>
<volume>45</volume>
<fpage>1113</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="pmid">15337311</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macnab</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>Expression of the exon 3 skipping form of GLAST, GLAST1a, in brain and retina</article-title>
<source/>Neuroreport
          <year>2006</year>
<volume>17</volume>
<fpage>1867</fpage>
<lpage>1870</lpage>
<pub-id pub-id-type="pmid">17179860</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huggett</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Mustafa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O’neal</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration</article-title>
<source/>Biochem Soc Trans
          <year>2002</year>
<volume>30</volume>
<fpage>890</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="pmid">12440940</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallejo-Illarramendi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Domercq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake</article-title>
<source/>J Neurochem
          <year>2005</year>
<volume>95</volume>
<fpage>341</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">16042756</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macnab</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>Central nervous system expression of the exon 9 skipping form of the glutamate transporter GLAST</article-title>
<source/>Neuroreport
          <year>2007</year>
<volume>18</volume>
<fpage>741</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="pmid">17471058</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Macnab</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Björkman</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Colditz</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>GLAST1b, the exon-9 skipping form of the glutamate-aspartate transporter EAAT1 is a sensitive marker of neuronal dysfunction in the hypoxic brain</article-title>
<source/>Neuroscience
          <year>2007</year>
<volume>149</volume>
<fpage>434</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">17869431</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Beasley</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Poronnik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>A new splice variant of the glutamate-aspartate transporter: cloning and immunolocalization of GLAST1c in rat, pig and human brains</article-title>
<source/>J Chem Neuroanat
          <year>2012</year>
<volume>43</volume>
<fpage>52</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">22026960</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Assignment of the gene SLC1A2 coding for the human glutamate transporter EAAT2 to human chromosome 11 bands p13-p12</article-title>
<source/>Cytogenet Cell Genet
          <year>1995</year>
<volume>71</volume>
<fpage>212</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="pmid">7587378</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype</article-title>
<source/>Neurochem Int
          <year>1998</year>
<volume>33</volume>
<fpage>479</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="pmid">10098717</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks-Kayal</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Munir</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>The glutamate transporter, GLT-1, is expressed in cultured hippocampal neurons</article-title>
<source/>Neurochem Int
          <year>1998</year>
<volume>33</volume>
<fpage>95</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">9761452</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain</article-title>
<source/>J Neurosci
          <year>1998</year>
<volume>18</volume>
<fpage>8751</fpage>
<lpage>8757</lpage>
<pub-id pub-id-type="pmid">9786982</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Delaney</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS</article-title>
<source/>J Neurosci
          <year>1996</year>
<volume>16</volume>
<fpage>2191</fpage>
<lpage>2207</lpage>
<pub-id pub-id-type="pmid">8601800</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furness</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Dehnes</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>AQ</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hamann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grutle</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Holmseth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Ullensvang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)</article-title>
<source/>Neuroscience
          <year>2008</year>
<volume>157</volume>
<fpage>80</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">18805467</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalandadze</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fournier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter</article-title>
<source/>J Neurosci
          <year>2004</year>
<volume>24</volume>
<fpage>5183</fpage>
<lpage>5192</lpage>
<pub-id pub-id-type="pmid">15175388</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gendreau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Voswinkel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torres-Salazar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Heidtmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Detro-Dassen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schmalzing</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hidalgo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fahlke</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>A trimeric quaternary structure is conserved in bacterial and human glutamate transporters</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>39505</fpage>
<lpage>39512</lpage>
<pub-id pub-id-type="pmid">15265858</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Northington</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Traystman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>GLT1, glial glutamate transporter, is transiently expressed in neurons and develops astrocyte specificity only after midgestation in the ovine fetal brain</article-title>
<source/>J Neurobiol
          <year>1999</year>
<volume>39</volume>
<fpage>515</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="pmid">10380073</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Longuemare</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Neuronal regulation of glutamate transporter subtype expression in astrocytes</article-title>
<source/>J Neurosci
          <year>1997</year>
<volume>17</volume>
<fpage>932</fpage>
<lpage>940</lpage>
<pub-id pub-id-type="pmid">8994048</pub-id>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Leszczyniecka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Volsky</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2003</year>
<volume>100</volume>
<fpage>1955</fpage>
<lpage>1960</lpage>
<pub-id pub-id-type="pmid">12578975</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauriat</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>McInnes</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders</article-title>
<source/>Mol Psychiatry
          <year>2007</year>
<volume>12</volume>
<fpage>1065</fpage>
<lpage>1078</lpage>
<pub-id pub-id-type="pmid">17684493</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wiessner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain</article-title>
<source/>Neurochem Int
          <year>2004</year>
<volume>45</volume>
<fpage>1095</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="pmid">15337309</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utsunomiya-Tate</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Endou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Tissue specific variants of glutamate transporter GLT-1</article-title>
<source/>FEBS Lett
          <year>1997</year>
<volume>416</volume>
<fpage>312</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="pmid">9373176</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauriat</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Dracheva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schmeidler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McInnes</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain</article-title>
<source/>Neuroscience
          <year>2006</year>
<volume>137</volume>
<fpage>843</fpage>
<lpage>851</lpage>
<pub-id pub-id-type="pmid">16297566</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmseth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Real</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lehre</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Leergaard</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Bjaalie</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>162</volume>
<fpage>1055</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="pmid">19328838</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Asan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Kugler</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system</article-title>
<source/>Neuroscience
          <year>2002</year>
<volume>109</volume>
<fpage>45</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">11784699</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reye</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>Distribution of two splice variants of the glutamate transporter GLT1 in the retinas of humans, monkeys, rabbits, rats, cats, and chickens</article-title>
<source/>J Comp Neurol
          <year>2002</year>
<volume>445</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">11891650</pub-id>
</element-citation>
</ref>
<ref id="B80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Underhill</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Differential regulation of two isoforms of the glial glutamate transporter EAAT2 by DLG1 and CaMKII</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<fpage>5260</fpage>
<lpage>5270</lpage>
<pub-id pub-id-type="pmid">25834051</pub-id>
</element-citation>
</ref>
<ref id="B81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-González</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>García-Tardón</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giménez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zafra</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Splice variants of the glutamate transporter GLT1 form hetero-oligomers that interact with PSD-95 and NMDA receptors</article-title>
<source/>J Neurochem
          <year>2009</year>
<volume>110</volume>
<fpage>264</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="pmid">19457061</pub-id>
</element-citation>
</ref>
<ref id="B82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Donovan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders</article-title>
<source/>NPJ Schizophr
          <year>2017</year>
<volume>3</volume>
<fpage>32</fpage>
<pub-id pub-id-type="pmid">28935880</pub-id>
</element-citation>
</ref>
<ref id="B83">
<label>83</label>
<element-citation publication-type="journal">
<collab>Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, Jones EG</collab>
<article-title>Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2005</year>
<volume>102</volume>
<fpage>15653</fpage>
<lpage>15658</lpage>
<pub-id pub-id-type="pmid">16230605</pub-id>
</element-citation>
</ref>
<ref id="B84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue</article-title>
<source/>Curr Drug Targets
          <year>2013</year>
<volume>14</volume>
<fpage>1225</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="pmid">23469922</pub-id>
</element-citation>
</ref>
<ref id="B85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernstein</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bogerts</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy</article-title>
<source/>Expert Rev Neurother
          <year>2009</year>
<volume>9</volume>
<fpage>1059</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="pmid">19589054</pub-id>
</element-citation>
</ref>
<ref id="B86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Targeting astrocytes in bipolar disorder</article-title>
<source/>Expert Rev Neurother
          <year>2016</year>
<volume>16</volume>
<fpage>649</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="pmid">27015045</pub-id>
</element-citation>
</ref>
<ref id="B87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>FGF2 blocks PTSD symptoms via an astrocyte-based mechanism</article-title>
<source/>Behav Brain Res
          <year>2013</year>
<volume>256</volume>
<fpage>472</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="pmid">24013012</pub-id>
</element-citation>
</ref>
<ref id="B88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hellstrom</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Gershenfeld</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers</article-title>
<source/>Biol Psychiatry
          <year>2011</year>
<volume>70</volume>
<fpage>312</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="pmid">21571253</pub-id>
</element-citation>
</ref>
<ref id="B89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres-Platas</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Hercher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Davoli</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Maussion</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Labonté</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides</article-title>
<source/>Neuropsychopharmacology
          <year>2011</year>
<volume>36</volume>
<fpage>2650</fpage>
<lpage>2658</lpage>
<pub-id pub-id-type="pmid">21814185</pub-id>
</element-citation>
</ref>
<ref id="B90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moghaddam</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Javitt</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</article-title>
<source/>Neuropsychopharmacology
          <year>2012</year>
<volume>37</volume>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">21956446</pub-id>
</element-citation>
</ref>
<ref id="B91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Sousa</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Loch</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Brunoni</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Henter</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Zarate</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Machado-Vieira</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders</article-title>
<source/>Neuropsychopharmacology
          <year>2017</year>
<volume>42</volume>
<fpage>787</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="pmid">27510426</pub-id>
</element-citation>
</ref>
<ref id="B92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Phencyclidine-induced psychosis</article-title>
<source/>Am J Psychiatry
          <year>1978</year>
<volume>135</volume>
<fpage>1081</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="pmid">696930</pub-id>
</element-citation>
</ref>
<ref id="B93">
<label>93</label>
<element-citation publication-type="journal">
<collab>Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS</collab>
<article-title>Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</article-title>
<source/>Arch Gen Psychiatry
          <year>1994</year>
<volume>51</volume>
<fpage>199</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">8122957</pub-id>
</element-citation>
</ref>
<ref id="B94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umbricht</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Koller</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vollenweider</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Hell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Javitt</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia</article-title>
<source/>Arch Gen Psychiatry
          <year>2000</year>
<volume>57</volume>
<fpage>1139</fpage>
<lpage>1147</lpage>
<pub-id pub-id-type="pmid">11115327</pub-id>
</element-citation>
</ref>
<ref id="B95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fung</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Hardan</surname>
<given-names>AY</given-names>
</name>
</person-group>
<article-title>Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date</article-title>
<source/>CNS Drugs
          <year>2015</year>
<volume>29</volume>
<fpage>453</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">26104862</pub-id>
</element-citation>
</ref>
<ref id="B96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akutagava-Martins</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Salatino-Oliveira</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Genro</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Contini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Polanczyk</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zeni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chazan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kieling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anselmi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Menezes</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2014</year>
<volume>165B</volume>
<fpage>502</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="pmid">24985920</pub-id>
</element-citation>
</ref>
<ref id="B97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Werner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kohl</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kugel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shushakova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ohrmann</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Hyperactivity and impulsivity in adult attention-deficit/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex</article-title>
<source/>World J Biol Psychiatry
          <year>2016</year>
<fpage>1</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="B98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danysz</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Mobius</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Stoffler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Quack</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease--a unified glutamatergic hypothesis on the mechanism of action</article-title>
<source/>Neurotox Res
          <year>2000</year>
<volume>2</volume>
<fpage>85</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">16787834</pub-id>
</element-citation>
</ref>
<ref id="B99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francis</surname>
<given-names>PT</given-names>
</name>
</person-group>
<article-title>Glutamatergic systems in Alzheimer’s disease</article-title>
<source/>Int J Geriatr Psychiatry
          <year>2003</year>
<volume>18</volume>
<fpage>S15</fpage>
<lpage>S21</lpage>
<pub-id pub-id-type="pmid">12973746</pub-id>
</element-citation>
</ref>
<ref id="B100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spencer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kalivas</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2017</year>
<volume>20</volume>
<fpage>797</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="pmid">28605494</pub-id>
</element-citation>
</ref>
<ref id="B101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gegelashvili</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bjerrum</surname>
<given-names>OJ</given-names>
</name>
</person-group>
<article-title>Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology</article-title>
<source/>Adv Neurobiol
          <year>2017</year>
<volume>16</volume>
<fpage>225</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="pmid">28828613</pub-id>
</element-citation>
</ref>
<ref id="B102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Locatelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pirovano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Glutamate EAAT1 transporter genetic variants influence cognitive deficits in bipolar disorder</article-title>
<source/>Psychiatry Res
          <year>2015</year>
<volume>226</volume>
<fpage>407</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="pmid">25660734</pub-id>
</element-citation>
</ref>
<ref id="B103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riberto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Poletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brioschi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Excitatory amino acid transporters 1 affects corticolimbic circuitry during implicit processing of negative emotional stimuli in bipolar disorder</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2017</year>
<volume>27</volume>
<fpage>S712</fpage>
</element-citation>
</ref>
<ref id="B104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spangaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bosia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanoletti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bechi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mariachiara</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pirovano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Smeraldi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cavallaro</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia</article-title>
<source/>Pharmacogenomics
          <year>2014</year>
<volume>15</volume>
<fpage>925</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="pmid">24956246</pub-id>
</element-citation>
</ref>
<ref id="B105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kerman</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Barchas</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>16</volume>
<fpage>634</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="pmid">20386568</pub-id>
</element-citation>
</ref>
<ref id="B106">
<label>106</label>
<element-citation publication-type="journal">
<collab>Medina A, Burke S, Thompson RC, Bunney W Jr, Myers RM, Schatzberg A, Akil H, Watson SJ</collab>
<article-title>Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder</article-title>
<source/>J Psychiatr Res
          <year>2013</year>
<volume>47</volume>
<fpage>1150</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="pmid">23706640</pub-id>
</element-citation>
</ref>
<ref id="B107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McOmish</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Pavey</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hopper</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Udawela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scarr</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia</article-title>
<source/>J Affect Disord
          <year>2016</year>
<volume>190</volume>
<fpage>241</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="pmid">26521087</pub-id>
</element-citation>
</ref>
<ref id="B108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>FGF2 alleviates PTSD symptoms in rats by restoring GLAST function in astrocytes via the JAK/STAT pathway</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2015</year>
<volume>25</volume>
<fpage>1287</fpage>
<lpage>1299</lpage>
<pub-id pub-id-type="pmid">25979764</pub-id>
</element-citation>
</ref>
<ref id="B109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Iversen</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Gjerstad</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Taubøll</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate</article-title>
<source/>J Neurochem
          <year>2001</year>
<volume>77</volume>
<fpage>1285</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="pmid">11389179</pub-id>
</element-citation>
</ref>
<ref id="B110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguirre</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rosas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>López-Bayghen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ortega</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1</article-title>
<source/>Neurochem Int
          <year>2008</year>
<volume>52</volume>
<fpage>1322</fpage>
<lpage>1331</lpage>
<pub-id pub-id-type="pmid">18336953</pub-id>
</element-citation>
</ref>
<ref id="B111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghodke-Puranik</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Thorn</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lamba</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Leeder</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Valproic acid pathway: pharmacokinetics and pharmacodynamics</article-title>
<source/>Pharmacogenet Genomics
          <year>2013</year>
<volume>23</volume>
<fpage>236</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="pmid">23407051</pub-id>
</element-citation>
</ref>
<ref id="B112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rachi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ninomiya</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fukumaki</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2007</year>
<volume>144B</volume>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="pmid">17221839</pub-id>
</element-citation>
</ref>
<ref id="B113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilmsdorff</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Blaich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Treutlein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schneider-Axmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Rietschel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment</article-title>
<source/>World J Biol Psychiatry
          <year>2013</year>
<volume>14</volume>
<fpage>490</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="pmid">22424243</pub-id>
</element-citation>
</ref>
<ref id="B114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Harotunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia</article-title>
<source/>Schizophr Res
          <year>2008</year>
<volume>104</volume>
<fpage>108</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">18678470</pub-id>
</element-citation>
</ref>
<ref id="B115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia</article-title>
<source/>Am J Psychiatry
          <year>2001</year>
<volume>158</volume>
<fpage>1393</fpage>
<lpage>1399</lpage>
<pub-id pub-id-type="pmid">11532723</pub-id>
</element-citation>
</ref>
<ref id="B116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scarr</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Udawela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor</article-title>
<source/>Mol Psychiatry
          <year>2018</year>
<volume>23</volume>
<fpage>295</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="pmid">27801890</pub-id>
</element-citation>
</ref>
<ref id="B117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Baykiz</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Gershenfeld</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex</article-title>
<source/>BMC Genomics
          <year>2007</year>
<volume>8</volume>
<fpage>413</fpage>
<pub-id pub-id-type="pmid">17997842</pub-id>
</element-citation>
</ref>
<ref id="B118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeira</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mamdani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Lebel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rehal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klempan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gratton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benkelfat</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<fpage>e6585</fpage>
<pub-id pub-id-type="pmid">19668376</pub-id>
</element-citation>
</ref>
<ref id="B119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia</article-title>
<source/>Schizophr Res
          <year>2010</year>
<volume>117</volume>
<fpage>92</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">19716271</pub-id>
</element-citation>
</ref>
<ref id="B120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heilig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist</article-title>
<source/>Biol Psychiatry
          <year>2008</year>
<volume>64</volume>
<fpage>810</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="pmid">18550032</pub-id>
</element-citation>
</ref>
<ref id="B121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Benesh</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lauriat</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>823</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="pmid">26416546</pub-id>
</element-citation>
</ref>
<ref id="B122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bragina</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1</article-title>
<source/>Mol Psychiatry
          <year>2003</year>
<volume>8</volume>
<fpage>12</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">12556903</pub-id>
</element-citation>
</ref>
<ref id="B123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanahashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamamura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Motomura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes</article-title>
<source/>Br J Pharmacol
          <year>2012</year>
<volume>165</volume>
<fpage>1543</fpage>
<lpage>1555</lpage>
<pub-id pub-id-type="pmid">21880034</pub-id>
</element-citation>
</ref>
<ref id="B124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Butchbach</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Translational control of glial glutamate transporter EAAT2 expression</article-title>
<source/>J Biol Chem
          <year>2007</year>
<volume>282</volume>
<fpage>1727</fpage>
<lpage>1737</lpage>
<pub-id pub-id-type="pmid">17138558</pub-id>
</element-citation>
</ref>
<ref id="B125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bayatti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Clement</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Witan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Figiel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Engele</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Behl</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<fpage>34924</fpage>
<lpage>34932</lpage>
<pub-id pub-id-type="pmid">16079146</pub-id>
</element-citation>
</ref>
<ref id="B126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Autry</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Grillo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Piroli</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</name>
</person-group>
<article-title>Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus</article-title>
<source/>Neuroendocrinology
          <year>2006</year>
<volume>83</volume>
<fpage>371</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="pmid">17028421</pub-id>
</element-citation>
</ref>
<ref id="B127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klempan</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Sequeira</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Canetti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lalovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>ffrench-Mullen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression</article-title>
<source/>Mol Psychiatry
          <year>2009</year>
<volume>14</volume>
<fpage>175</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">17938633</pub-id>
</element-citation>
</ref>
<ref id="B128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vollmayr</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gebicke-Haerter</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Henn</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression</article-title>
<source/>Neuropharmacology
          <year>2010</year>
<volume>58</volume>
<fpage>465</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="pmid">19747495</pub-id>
</element-citation>
</ref>
<ref id="B129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>ZL</given-names>
</name>
</person-group>
<article-title>Involvement of pGluR1, EAAT2 and EAAT3 in offspring depression induced by prenatal stress</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>250</volume>
<fpage>333</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="pmid">23694703</pub-id>
</element-citation>
</ref>
<ref id="B130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Rosell</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Spedding</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2004</year>
<volume>101</volume>
<fpage>2179</fpage>
<lpage>2184</lpage>
<pub-id pub-id-type="pmid">14766991</pub-id>
</element-citation>
</ref>
<ref id="B131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gaskins</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shekhar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Glia mechanisms in mood regulation: a novel model of mood disorders</article-title>
<source/>Psychopharmacology (Berl)
          <year>2007</year>
<volume>191</volume>
<fpage>55</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">17225169</pub-id>
</element-citation>
</ref>
<ref id="B132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakrabarty</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Christopher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Glutamatergic dysfunction in OCD</article-title>
<source/>Neuropsychopharmacology
          <year>2005</year>
<volume>30</volume>
<fpage>1735</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">15841109</pub-id>
</element-citation>
</ref>
<ref id="B133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakrabarty</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mahadevan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Christopher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder</article-title>
<source/>Neuropsychopharmacology
          <year>2009</year>
<volume>34</volume>
<fpage>2489</fpage>
<lpage>2496</lpage>
<pub-id pub-id-type="pmid">19675532</pub-id>
</element-citation>
</ref>
<ref id="B134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittenger</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Glutamatergic agents for OCD and related disorders</article-title>
<source/>Curr Treat Options Psychiatry
          <year>2015</year>
<volume>2</volume>
<fpage>271</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="pmid">26301176</pub-id>
</element-citation>
</ref>
<ref id="B135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tanimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iino</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Soma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Aizawa</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice</article-title>
<source/>Neuropsychopharmacology
          <year>2015</year>
<volume>40</volume>
<fpage>1569</fpage>
<lpage>1579</lpage>
<pub-id pub-id-type="pmid">25662838</pub-id>
</element-citation>
</ref>
<ref id="B136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rapp</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Donev</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gebicke-Haerter</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Thome</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Fluoxetine treatment induces EAAT2 expression in rat brain</article-title>
<source/>J Neural Transm (Vienna)
          <year>2011</year>
<volume>118</volume>
<fpage>849</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="pmid">21161710</pub-id>
</element-citation>
</ref>
<ref id="B137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Stress-induced structural remodeling in hippocampus: prevention by lithium treatment</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2004</year>
<volume>101</volume>
<fpage>3973</fpage>
<lpage>3978</lpage>
<pub-id pub-id-type="pmid">15001711</pub-id>
</element-citation>
</ref>
<ref id="B138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spangaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bosia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanoletti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bechi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cocchi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pirovano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Smeraldi</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia</article-title>
<source/>Neurosci Lett
          <year>2012</year>
<volume>522</volume>
<fpage>151</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">22728822</pub-id>
</element-citation>
</ref>
<ref id="B139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Radaelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bosia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buonocore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pirovano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cavallaro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smeraldi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia</article-title>
<source/>Eur Psychiatry
          <year>2014</year>
<volume>29</volume>
<fpage>219</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="pmid">24076156</pub-id>
</element-citation>
</ref>
<ref id="B140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohnuma</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tessler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>McKenna</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Emson</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus</article-title>
<source/>Brain Res Mol Brain Res
          <year>2000</year>
<volume>85</volume>
<fpage>24</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">11146103</pub-id>
</element-citation>
</ref>
<ref id="B141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohnuma</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Augood</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>McKenna</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Emson</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia</article-title>
<source/>Brain Res Mol Brain Res
          <year>1998</year>
<volume>56</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="pmid">9602129</pub-id>
</element-citation>
</ref>
<ref id="B142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Melone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vallejo-Illarramendi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics</article-title>
<source/>Glia
          <year>2005</year>
<volume>49</volume>
<fpage>451</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="pmid">15494981</pub-id>
</element-citation>
</ref>
<ref id="B143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mount</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia</article-title>
<source/>Schizophr Res
          <year>2014</year>
<volume>154</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">24560881</pub-id>
</element-citation>
</ref>
<ref id="B144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petroianu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>May</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Braus</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Henn</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain</article-title>
<source/>Neurosci Lett
          <year>2003</year>
<volume>347</volume>
<fpage>81</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">12873733</pub-id>
</element-citation>
</ref>
<ref id="B145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Wade</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lidsky</surname>
<given-names>TI</given-names>
</name>
</person-group>
<article-title>Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum</article-title>
<source/>Neuroreport
          <year>1998</year>
<volume>9</volume>
<fpage>133</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">9592062</pub-id>
</element-citation>
</ref>
<ref id="B146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vitellaro-Zuccarello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vallejo-Illarramendi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pérez-Samartin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cozzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pellegrini-Giampietro</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine</article-title>
<source/>Mol Psychiatry
          <year>2001</year>
<volume>6</volume>
<fpage>380</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="pmid">11443521</pub-id>
</element-citation>
</ref>
<ref id="B147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallejo-Illarramendi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torres-Ramos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Melone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures</article-title>
<source/>Glia
          <year>2005</year>
<volume>50</volume>
<fpage>276</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">15739191</pub-id>
</element-citation>
</ref>
<ref id="B148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsugami</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Tanemura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mieda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakatomi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Obata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashikawa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2006</year>
<volume>103</volume>
<fpage>12161</fpage>
<lpage>12166</lpage>
<pub-id pub-id-type="pmid">16880397</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>